Overview - Schedule of Restatement of Previously Issued Consolidated Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands |
3 Months Ended |
6 Months Ended |
|
|
|
Jun. 30, 2020 |
Mar. 31, 2020 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Dec. 31, 2019 |
Jul. 15, 2019 |
| Cash and cash equivalents |
|
|
|
|
|
|
$ 15,106
|
$ 2,321
|
|
| Accounts receivable, net of allowance for doubtful accounts |
|
|
|
|
|
|
7,239
|
10,338
|
|
| Other current assets |
|
|
|
|
|
|
3,751
|
3,851
|
|
| Total current assets |
|
|
|
|
|
|
26,096
|
16,510
|
|
| Property and equipment, net |
|
|
|
|
|
|
7,249
|
6,814
|
|
| Other intangible assets, net |
|
|
|
|
|
|
13,619
|
15,849
|
|
| Goodwill |
|
|
|
|
|
|
8,433
|
8,433
|
$ 8,300
|
| Operating lease right of use assets |
|
|
|
|
|
|
5,172
|
|
|
| Other long-term assets |
|
|
|
|
|
|
42
|
42
|
|
| Total assets |
|
|
|
|
|
|
60,611
|
51,540
|
|
| Accounts payable |
|
|
|
|
|
|
3,348
|
4,709
|
|
| Accrued salary and bonus |
|
|
|
|
|
|
2,247
|
2,341
|
|
| Other accrued expenses |
|
|
|
|
|
|
9,737
|
9,476
|
|
| Current liabilities from discontinued operations |
|
|
|
|
|
|
766
|
766
|
|
| Total current liabilities |
|
|
|
|
|
|
16,098
|
17,292
|
|
| Contingent consideration |
|
|
|
|
|
|
2,207
|
2,391
|
|
| Operating lease liabilities, net of current portion |
|
|
|
|
|
|
3,940
|
2,591
|
|
| Line of credit |
|
|
|
|
|
|
3,400
|
3,000
|
|
| Other long-term liabilities |
|
|
|
|
|
|
4,557
|
4,573
|
|
| Total liabilities |
|
|
|
|
|
|
30,202
|
29,847
|
|
| Commitments and contingencies (Note 8) |
|
|
|
|
|
|
|
|
|
| Preferred stock value |
|
|
|
|
|
|
|
|
|
| Common stock value |
|
|
|
|
|
|
402
|
393
|
|
| Additional paid-in capital |
|
|
|
|
|
|
182,980
|
182,514
|
|
| Accumulated deficit |
|
|
|
|
|
|
(197,739)
|
(185,665)
|
|
| Treasury stock, at cost (11,781 shares) |
|
|
|
|
|
|
(1,770)
|
(1,721)
|
|
| Total stockholders' equity |
$ 6,838
|
$ 6,838
|
$ 13,346
|
$ 32,938
|
$ (16,127)
|
$ 32,938
|
(16,127)
|
(4,479)
|
|
| Total liabilities and stockholders' equity |
|
|
|
|
|
|
14,075
|
25,368
|
|
| Total liabilities, preferred stock and stockholders' equity |
|
|
|
|
|
|
60,611
|
51,540
|
|
| Revenue, net |
5,446
|
|
6,270
|
|
14,504
|
12,280
|
|
|
|
| Cost of revenue |
3,850
|
|
3,031
|
|
9,963
|
5,654
|
|
|
|
| Gross profit |
1,596
|
|
3,239
|
|
4,541
|
6,626
|
|
|
|
| Sales and marketing |
1,596
|
|
2,959
|
|
4,077
|
5,369
|
|
|
|
| Research and development |
550
|
|
647
|
|
1,360
|
1,175
|
|
|
|
| General and administrative |
4,107
|
|
2,788
|
|
8,999
|
5,122
|
|
|
|
| Acquisition related expense |
|
|
1,295
|
|
|
1,696
|
|
|
|
| Acquisition related amortization expense |
1,115
|
|
897
|
|
2,230
|
1,794
|
|
|
|
| Total operating expenses |
7,368
|
|
8,586
|
|
16,666
|
15,156
|
|
|
|
| Operating loss |
(5,772)
|
|
(5,347)
|
|
(12,125)
|
(8,530)
|
|
|
|
| Interest accretion |
(167)
|
|
(91)
|
|
(276)
|
(220)
|
|
|
|
| Other income (expense), net |
438
|
|
74
|
|
485
|
123
|
|
|
|
| Loss from continuing operations before tax |
(5,501)
|
|
(5,364)
|
|
(11,916)
|
(8,627)
|
|
|
|
| Provision for income taxes |
13
|
|
5
|
|
28
|
10
|
|
|
|
| Loss from continuing operations, net of tax |
(5,514)
|
|
(5,369)
|
|
(11,944)
|
(8,637)
|
|
|
|
| Less adjustment for preferred stock deemed dividend |
|
|
|
|
3,033
|
|
|
|
|
| Loss from continuing operations attributable to common stockholders |
(5,580)
|
|
(5,304)
|
|
(12,074)
|
(8,630)
|
|
|
|
| Loss from discontinued operations, net of tax |
(66)
|
|
65
|
|
(130)
|
7
|
|
|
|
| Net loss attributable to common stockholders |
$ (5,580)
|
|
$ (5,304)
|
|
$ (15,107)
|
$ (8,630)
|
|
|
|
| From continuing operations |
$ (1.37)
|
|
$ (1.41)
|
|
$ (3.73)
|
$ (2.36)
|
|
|
|
| From discontinued operations |
(0.01)
|
|
0.02
|
|
(0.03)
|
|
|
|
|
| Net loss per basic and diluted share of common stock |
$ (1.38)
|
|
$ (1.39)
|
|
$ (3.76)
|
$ (2.36)
|
|
|
|
| Basic |
4,033,000
|
|
3,813,000
|
|
4,018,000
|
3,665,000
|
|
|
|
| Diluted |
4,033,000
|
|
3,813,000
|
|
4,018,000
|
3,665,000
|
|
|
|
| Balance |
$ 6,838
|
(4,479)
|
$ 35,771
|
32,938
|
$ (4,479)
|
$ 32,938
|
|
|
|
| Common stock issued |
|
1
|
73
|
1
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
484
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
5,962
|
|
|
|
|
|
| Treasury stock purchased |
(49)
|
|
|
(32)
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
(828)
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
2,205
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
(2,205)
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
400
|
418
|
205
|
266
|
|
|
|
|
|
| Adoption of ASC 842 |
|
|
|
55
|
|
|
|
|
|
| Net loss |
(5,580)
|
(6,494)
|
(5,304)
|
(3,419)
|
(15,107)
|
(8,630)
|
|
|
|
| Balance |
(16,127)
|
6,838
|
13,346
|
35,771
|
(16,127)
|
13,346
|
|
|
|
| Net loss |
|
|
|
|
(12,074)
|
(8,630)
|
|
|
|
| Depreciation and amortization |
|
|
|
|
2,708
|
1,917
|
|
|
|
| Interest accretion |
|
|
|
|
276
|
220
|
|
|
|
| Mark to market on warrants |
|
|
|
|
(49)
|
(45)
|
|
|
|
| Stock-based compensation |
818
|
|
500
|
|
818
|
990
|
|
|
|
| Bad debt expense |
|
|
|
|
250
|
499
|
|
|
|
| Other gains and expenses, net |
|
|
|
|
0
|
18
|
|
|
|
| Decrease (increase) in accounts receivable |
|
|
|
|
2,849
|
(3,982)
|
|
|
|
| (Increase) decrease in other current assets |
|
|
|
|
(788)
|
(252)
|
|
|
|
| (Decrease) increase in accounts payable |
|
|
|
|
(1,361)
|
530
|
|
|
|
| (Decrease) increase in accrued salaries and bonus |
|
|
|
|
(94)
|
(261)
|
|
|
|
| (Decrease) increase in accrued liabilities |
|
|
|
|
759
|
1,097
|
|
|
|
| Increase in long-term liabilities |
|
|
|
|
33
|
114
|
|
|
|
| Net cash used in operating activities |
|
|
|
|
(6,673)
|
(7,785)
|
|
|
|
| Purchase of property and equipment |
|
|
|
|
(913)
|
(48)
|
|
|
|
| Sale of property and equipment |
|
|
|
|
0
|
13
|
|
|
|
| Net cash provided by investing activity |
|
|
|
|
(913)
|
(35)
|
|
|
|
| Issuance of common stock, net of expenses |
|
|
|
|
434
|
5,962
|
|
|
|
| Borrowings on Line of Credit, net |
|
|
|
|
400
|
|
|
|
|
| Issuance of Series B preferred stock, net of expenses |
|
|
|
|
19,537
|
|
|
|
|
| Net cash provided by financing activities |
|
|
|
|
20,371
|
5,962
|
|
|
|
| Net increase (decrease) in cash and cash equivalents |
|
|
|
|
12,785
|
(1,858)
|
|
|
|
| Cash and cash equivalents - beginning |
|
2,321
|
5,377
|
6,068
|
2,321
|
6,068
|
|
|
|
| Cash and cash equivalents - ending |
15,106
|
|
4,210
|
5,377
|
15,106
|
4,210
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
402
|
402
|
383
|
382
|
402
|
383
|
402
|
393
|
|
| Balance |
$ 402
|
$ 393
|
$ 382
|
$ 287
|
$ 393
|
$ 287
|
|
|
|
| Balance, shares |
4,055,000
|
3,932,000
|
3,819,000
|
2,877,000
|
3,932,000
|
2,877,000
|
|
|
|
| Common stock issued |
|
$ 1
|
$ 1
|
$ 1
|
|
|
|
|
|
| Common stock issued, shares |
|
37,000
|
10,000
|
9,000
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Restricted stock issued, shares |
|
6,000
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
$ 8
|
|
|
|
|
|
|
|
| Common stock issued through market sales, shares |
|
80,000
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
$ 94
|
|
|
|
|
|
| Common stock issued through offerings, shares |
|
|
|
933
|
|
|
|
|
|
| Treasury stock purchased |
|
|
|
|
|
|
|
|
|
| Treasury stock purchased, shares |
|
|
|
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
| Adoption of ASC 842 |
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
|
|
|
|
|
|
| Balance |
$ 402
|
$ 402
|
$ 383
|
$ 382
|
$ 402
|
$ 383
|
|
|
|
| Balance, shares |
4,055,000
|
4,055,000
|
3,829,000
|
3,819,000
|
4,055,000
|
3,829,000
|
|
|
|
| Treasury Stock [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
$ (1,721)
|
$ (1,721)
|
$ (1,712)
|
$ (1,712)
|
$ (1,770)
|
$ (1,712)
|
(1,770)
|
(1,721)
|
|
| Balance |
$ (1,721)
|
$ (1,721)
|
$ (1,712)
|
$ (1,680)
|
$ (1,721)
|
$ (1,680)
|
|
|
|
| Balance, shares |
12,000
|
12,000
|
10,000
|
7,000
|
12,000
|
7,000
|
|
|
|
| Common stock issued |
|
|
|
|
|
|
|
|
|
| Common stock issued, shares |
|
|
|
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Restricted stock issued, shares |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales, shares |
|
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
|
|
|
|
|
|
| Common stock issued through offerings, shares |
|
|
|
|
|
|
|
|
|
| Treasury stock purchased |
$ (49)
|
|
|
$ (32)
|
|
|
|
|
|
| Treasury stock purchased, shares |
7,000
|
|
|
3,000
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
| Adoption of ASC 842 |
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
|
|
|
|
|
|
| Balance |
$ (1,770)
|
$ (1,721)
|
$ (1,712)
|
$ (1,712)
|
$ (1,770)
|
$ (1,712)
|
|
|
|
| Balance, shares |
19,000
|
12,000
|
10,000
|
10,000
|
19,000
|
10,000
|
|
|
|
| Additional Paid-in Capital [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
$ 182,580
|
$ 182,580
|
$ 182,231
|
$ 181,954
|
$ 182,980
|
$ 182,231
|
182,980
|
182,514
|
|
| Balance |
182,580
|
182,514
|
181,954
|
175,820
|
182,514
|
175,820
|
|
|
|
| Common stock issued |
|
|
72
|
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
476
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
5,868
|
|
|
|
|
|
| Treasury stock purchased |
|
|
|
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
(828)
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
2,205
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
(2,205)
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
400
|
418
|
205
|
266
|
|
|
|
|
|
| Adoption of ASC 842 |
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
|
|
|
|
|
|
| Balance |
182,980
|
182,580
|
182,231
|
181,954
|
182,980
|
182,231
|
|
|
|
| Accumulated Deficit [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
(192,159)
|
(192,159)
|
(167,556)
|
(162,252)
|
(197,739)
|
(167,556)
|
(197,739)
|
(185,665)
|
|
| Balance |
(192,159)
|
(185,665)
|
(162,252)
|
(158,981)
|
(185,665)
|
(158,981)
|
|
|
|
| Common stock issued |
|
|
|
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
|
|
|
|
|
|
| Treasury stock purchased |
|
|
|
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
| Adoption of ASC 842 |
|
|
|
55
|
|
|
|
|
|
| Net loss |
(5,580)
|
(6,494)
|
(5,304)
|
(3,326)
|
|
|
|
|
|
| Balance |
(197,739)
|
(192,159)
|
(167,556)
|
(162,252)
|
$ (197,739)
|
(167,556)
|
|
|
|
| Series B [Member] |
|
|
|
|
|
|
|
|
|
| Preferred stock value |
|
|
|
|
|
|
46,536
|
|
|
| Common stock issued, shares |
|
|
|
|
27,000
|
|
|
|
|
| As Previously Reported [Member] |
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
|
|
|
|
|
15,106
|
|
|
| Accounts receivable, net of allowance for doubtful accounts |
|
|
|
|
|
|
7,239
|
|
|
| Other current assets |
|
|
|
|
|
|
3,751
|
|
|
| Total current assets |
|
|
|
|
|
|
26,096
|
|
|
| Property and equipment, net |
|
|
|
|
|
|
7,249
|
|
|
| Other intangible assets, net |
|
|
|
|
|
|
31,439
|
|
|
| Goodwill |
|
|
|
|
|
|
8,433
|
|
|
| Operating lease right of use assets |
|
|
|
|
|
|
5,172
|
|
|
| Other long-term assets |
|
|
|
|
|
|
42
|
|
|
| Total assets |
|
|
|
|
|
|
78,431
|
|
|
| Accounts payable |
|
|
|
|
|
|
3,348
|
|
|
| Accrued salary and bonus |
|
|
|
|
|
|
2,247
|
|
|
| Other accrued expenses |
|
|
|
|
|
|
9,737
|
|
|
| Current liabilities from discontinued operations |
|
|
|
|
|
|
766
|
|
|
| Total current liabilities |
|
|
|
|
|
|
19,498
|
|
|
| Contingent consideration |
|
|
|
|
|
|
2,207
|
|
|
| Operating lease liabilities, net of current portion |
|
|
|
|
|
|
3,940
|
|
|
| Line of credit |
|
|
|
|
|
|
3,400
|
|
|
| Other long-term liabilities |
|
|
|
|
|
|
4,557
|
|
|
| Total liabilities |
|
|
|
|
|
|
30,202
|
|
|
| Commitments and contingencies (Note 8) |
|
|
|
|
|
|
|
|
|
| Common stock value |
|
|
|
|
|
|
402
|
|
|
| Additional paid-in capital |
|
|
|
|
|
|
182,980
|
|
|
| Accumulated deficit |
|
|
|
|
|
|
(179,919)
|
|
|
| Treasury stock, at cost (11,781 shares) |
|
|
|
|
|
|
(1,770)
|
|
|
| Total stockholders' equity |
6,838
|
6,838
|
|
|
$ 1,693
|
|
1,693
|
|
|
| Total liabilities and stockholders' equity |
|
|
|
|
|
|
31,895
|
|
|
| Total liabilities, preferred stock and stockholders' equity |
|
|
|
|
|
|
78,431
|
|
|
| Revenue, net |
5,446
|
|
6,270
|
|
14,645
|
12,280
|
|
|
|
| Cost of revenue |
3,850
|
|
3,031
|
|
9,963
|
5,654
|
|
|
|
| Gross profit |
1,596
|
|
3,239
|
|
4,682
|
6,626
|
|
|
|
| Sales and marketing |
1,596
|
|
2,959
|
|
4,077
|
5,369
|
|
|
|
| Research and development |
550
|
|
647
|
|
1,360
|
1,175
|
|
|
|
| General and administrative |
4,107
|
|
2,788
|
|
8,993
|
5,299
|
|
|
|
| Acquisition related expense |
|
|
1,295
|
|
|
1,696
|
|
|
|
| Acquisition related amortization expense |
1,031
|
|
813
|
|
2,062
|
1,626
|
|
|
|
| Total operating expenses |
7,284
|
|
8,502
|
|
16,492
|
15,165
|
|
|
|
| Operating loss |
(5,688)
|
|
(5,263)
|
|
(11,810)
|
(8,539)
|
|
|
|
| Interest accretion |
(167)
|
|
(91)
|
|
(276)
|
(220)
|
|
|
|
| Other income (expense), net |
438
|
|
74
|
|
485
|
123
|
|
|
|
| Loss from continuing operations before tax |
(5,417)
|
|
(5,280)
|
|
(11,601)
|
(8,636)
|
|
|
|
| Provision for income taxes |
13
|
|
5
|
|
28
|
10
|
|
|
|
| Loss from continuing operations, net of tax |
(5,430)
|
|
(5,285)
|
|
(11,629)
|
(8,646)
|
|
|
|
| Less adjustment for preferred stock deemed dividend |
|
|
|
|
(3,033)
|
|
|
|
|
| Loss from continuing operations attributable to common stockholders |
(5,430)
|
|
(5,285)
|
|
(14,662)
|
(8,646)
|
|
|
|
| Loss from discontinued operations, net of tax |
(66)
|
|
65
|
|
(130)
|
7
|
|
|
|
| Net loss attributable to common stockholders |
$ (5,496)
|
|
$ (5,220)
|
|
$ (14,792)
|
$ (8,639)
|
|
|
|
| From continuing operations |
$ (1.35)
|
|
$ (1.39)
|
|
$ (3.65)
|
$ (2.36)
|
|
|
|
| From discontinued operations |
(0.01)
|
|
0.02
|
|
(0.03)
|
|
|
|
|
| Net loss per basic and diluted share of common stock |
$ (1.36)
|
|
$ (1.37)
|
|
$ (3.68)
|
$ (2.36)
|
|
|
|
| Basic |
4,033,000
|
|
3,813,000
|
|
4,018,000
|
3,665,000
|
|
|
|
| Diluted |
4,033,000
|
|
3,813,000
|
|
4,018,000
|
3,665,000
|
|
|
|
| Balance |
$ 6,838
|
|
|
|
|
|
|
|
|
| Balance |
1,693
|
6,838
|
|
|
$ 1,693
|
|
|
|
|
| Net loss |
|
|
|
|
(11,759)
|
$ (8,639)
|
|
|
|
| Depreciation and amortization |
|
|
|
|
2,540
|
1,749
|
|
|
|
| Interest accretion |
|
|
|
|
276
|
220
|
|
|
|
| Mark to market on warrants |
|
|
|
|
(49)
|
(45)
|
|
|
|
| Stock-based compensation |
|
|
|
|
818
|
990
|
|
|
|
| Bad debt expense |
|
|
|
|
250
|
499
|
|
|
|
| Other gains and expenses, net |
|
|
|
|
|
18
|
|
|
|
| Decrease (increase) in accounts receivable |
|
|
|
|
2,708
|
(3,982)
|
|
|
|
| (Increase) decrease in other current assets |
|
|
|
|
(788)
|
(252)
|
|
|
|
| (Decrease) increase in accounts payable |
|
|
|
|
(1,464)
|
530
|
|
|
|
| (Decrease) increase in accrued salaries and bonus |
|
|
|
|
(94)
|
(141)
|
|
|
|
| (Decrease) increase in accrued liabilities |
|
|
|
|
856
|
1,154
|
|
|
|
| Increase in long-term liabilities |
|
|
|
|
33
|
114
|
|
|
|
| Net cash used in operating activities |
|
|
|
|
(6,673)
|
(7,785)
|
|
|
|
| Purchase of property and equipment |
|
|
|
|
(913)
|
(48)
|
|
|
|
| Sale of property and equipment |
|
|
|
|
|
13
|
|
|
|
| Net cash provided by investing activity |
|
|
|
|
(913)
|
(35)
|
|
|
|
| Issuance of common stock, net of expenses |
|
|
|
|
434
|
5,962
|
|
|
|
| Borrowings on Line of Credit, net |
|
|
|
|
400
|
|
|
|
|
| Issuance of Series B preferred stock, net of expenses |
|
|
|
|
19,537
|
|
|
|
|
| Net cash provided by financing activities |
|
|
|
|
20,371
|
5,962
|
|
|
|
| Net increase (decrease) in cash and cash equivalents |
|
|
|
|
12,785
|
(1,858)
|
|
|
|
| Cash and cash equivalents - beginning |
|
2,321
|
$ 5,377
|
6,068
|
2,321
|
6,068
|
|
|
|
| Cash and cash equivalents - ending |
15,106
|
|
4,210
|
5,377
|
15,106
|
4,210
|
|
|
|
| As Previously Reported [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
402
|
402
|
383
|
382
|
393
|
383
|
|
393
|
|
| Balance |
$ 402
|
$ 393
|
$ 382
|
$ 287
|
$ 393
|
$ 287
|
|
|
|
| Balance, shares |
4,055,000
|
3,932,000
|
3,819,000
|
2,877,000
|
3,932,000
|
2,877,000
|
|
|
|
| Common stock issued |
|
$ 1
|
$ 1
|
$ 1
|
|
|
|
|
|
| Common stock issued, shares |
|
37,000
|
10,000
|
9,000
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Restricted stock issued, shares |
|
6,000
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
$ 8
|
|
|
|
|
|
|
|
| Common stock issued through market sales, shares |
|
80,000
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
$ 94
|
|
|
|
|
|
| Common stock issued through offerings, shares |
|
|
|
933,000
|
|
|
|
|
|
| Balance |
|
$ 402
|
$ 383
|
$ 382
|
|
$ 383
|
|
|
|
| Balance, shares |
|
4,055,000
|
3,829,000
|
3,819,000
|
|
3,829,000
|
|
|
|
| As Previously Reported [Member] | Treasury Stock [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
$ (1,770)
|
$ (1,721)
|
$ (1,712)
|
$ (1,712)
|
$ (1,770)
|
$ (1,712)
|
(1,770)
|
(1,721)
|
|
| Balance |
$ (1,721)
|
$ (1,721)
|
$ (1,712)
|
$ (1,680)
|
$ (1,721)
|
$ (1,680)
|
|
|
|
| Balance, shares |
12,000
|
12,000
|
10,000
|
7,000
|
12,000
|
7,000
|
|
|
|
| Treasury stock purchased |
$ (49)
|
|
|
$ (32)
|
|
|
|
|
|
| Treasury stock purchased, shares |
7,000
|
|
|
3,000
|
|
|
|
|
|
| Balance |
$ (1,770)
|
$ (1,721)
|
$ (1,712)
|
$ (1,712)
|
$ (1,770)
|
$ (1,712)
|
|
|
|
| Balance, shares |
19,000
|
12,000
|
10,000
|
10,000
|
19,000
|
10,000
|
|
|
|
| As Previously Reported [Member] | Additional Paid-in Capital [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
$ 182,980
|
$ 182,580
|
$ 182,231
|
$ 181,954
|
$ 182,980
|
$ 182,231
|
182,980
|
182,514
|
|
| Balance |
182,580
|
182,514
|
181,954
|
175,820
|
182,514
|
175,820
|
|
|
|
| Common stock issued |
|
|
72
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
476
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
5,868
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
(828)
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
2,205
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
(2,205)
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
400
|
418
|
205
|
266
|
|
|
|
|
|
| Balance |
182,980
|
182,580
|
182,231
|
181,954
|
182,980
|
182,231
|
|
|
|
| As Previously Reported [Member] | Accumulated Deficit [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
(179,919)
|
(174,423)
|
(150,073)
|
(141,489)
|
(179,919)
|
(150,073)
|
(179,919)
|
(168,160)
|
|
| Balance |
(174,423)
|
(168,160)
|
(144,853)
|
(141,489)
|
(168,160)
|
(141,489)
|
|
|
|
| Adoption of ASC 842 |
|
|
|
55
|
|
|
|
|
|
| Net loss |
(5,496)
|
(6,263)
|
(5,220)
|
(3,419)
|
|
|
|
|
|
| Balance |
(179,919)
|
(174,423)
|
(150,073)
|
(144,853)
|
(179,919)
|
(150,073)
|
|
|
|
| As Previously Reported [Member] | Series B [Member] |
|
|
|
|
|
|
|
|
|
| Preferred stock value |
|
|
|
|
|
|
46,536
|
|
|
| Restatement Amount [Member] |
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
|
|
|
|
|
|
|
|
| Accounts receivable, net of allowance for doubtful accounts |
|
|
|
|
|
|
|
|
|
| Other current assets |
|
|
|
|
|
|
|
|
|
| Total current assets |
|
|
|
|
|
|
|
|
|
| Property and equipment, net |
|
|
|
|
|
|
|
|
|
| Other intangible assets, net |
|
|
|
|
|
|
(17,820)
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
| Operating lease right of use assets |
|
|
|
|
|
|
|
|
|
| Other long-term assets |
|
|
|
|
|
|
|
|
|
| Total assets |
|
|
|
|
|
|
(17,820)
|
|
|
| Accounts payable |
|
|
|
|
|
|
|
|
|
| Accrued salary and bonus |
|
|
|
|
|
|
|
|
|
| Other accrued expenses |
|
|
|
|
|
|
|
|
|
| Current liabilities from discontinued operations |
|
|
|
|
|
|
|
|
|
| Total current liabilities |
|
|
|
|
|
|
|
|
|
| Contingent consideration |
|
|
|
|
|
|
|
|
|
| Operating lease liabilities, net of current portion |
|
|
|
|
|
|
|
|
|
| Line of credit |
|
|
|
|
|
|
|
|
|
| Other long-term liabilities |
|
|
|
|
|
|
|
|
|
| Total liabilities |
|
|
|
|
|
|
|
|
|
| Commitments and contingencies (Note 8) |
|
|
|
|
|
|
|
|
|
| Common stock value |
|
|
|
|
|
|
|
|
|
| Additional paid-in capital |
|
|
|
|
|
|
|
|
|
| Accumulated deficit |
|
|
|
|
|
|
(17,820)
|
|
|
| Treasury stock, at cost (11,781 shares) |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
(17,736)
|
(17,736)
|
|
|
(17,820)
|
|
(17,820)
|
|
|
| Total liabilities and stockholders' equity |
|
|
|
|
|
|
(17,820)
|
|
|
| Total liabilities, preferred stock and stockholders' equity |
|
|
|
|
|
|
(17,820)
|
|
|
| Revenue, net |
|
|
|
|
(141)
|
|
|
|
|
| Cost of revenue |
|
|
|
|
|
|
|
|
|
| Gross profit |
|
|
|
|
(141)
|
|
|
|
|
| Sales and marketing |
|
|
|
|
|
|
|
|
|
| Research and development |
|
|
|
|
|
|
|
|
|
| General and administrative |
|
|
|
|
6
|
(177)
|
|
|
|
| Acquisition related expense |
|
|
|
|
|
|
|
|
|
| Acquisition related amortization expense |
84
|
|
84
|
|
168
|
168
|
|
|
|
| Total operating expenses |
84
|
|
84
|
|
174
|
(9)
|
|
|
|
| Operating loss |
(84)
|
|
(84)
|
|
(315)
|
9
|
|
|
|
| Interest accretion |
|
|
|
|
|
|
|
|
|
| Other income (expense), net |
|
|
|
|
|
|
|
|
|
| Loss from continuing operations before tax |
(84)
|
|
(84)
|
|
(315)
|
9
|
|
|
|
| Provision for income taxes |
|
|
|
|
|
|
|
|
|
| Loss from continuing operations, net of tax |
(84)
|
|
(84)
|
|
(315)
|
9
|
|
|
|
| Less adjustment for preferred stock deemed dividend |
|
|
|
|
|
|
|
|
|
| Loss from continuing operations attributable to common stockholders |
(84)
|
|
(84)
|
|
(315)
|
9
|
|
|
|
| Loss from discontinued operations, net of tax |
|
|
|
|
|
|
|
|
|
| Net loss attributable to common stockholders |
$ (84)
|
|
$ (84)
|
|
$ (315)
|
$ 9
|
|
|
|
| From continuing operations |
$ (0.02)
|
|
$ (0.02)
|
|
$ (0.08)
|
$ 0.00
|
|
|
|
| From discontinued operations |
|
|
|
|
|
|
|
|
|
| Net loss per basic and diluted share of common stock |
$ (0.02)
|
|
$ (0.02)
|
|
$ (0.08)
|
|
|
|
|
| Basic |
4,033,000
|
|
3,813,000
|
|
4,018,000
|
3,665,000
|
|
|
|
| Diluted |
4,033,000
|
|
3,813,000
|
|
4,018,000
|
3,665,000
|
|
|
|
| Balance |
$ (17,736)
|
|
|
|
|
|
|
|
|
| Balance |
(17,820)
|
(17,736)
|
|
|
$ (17,820)
|
|
|
|
|
| Net loss |
|
|
|
|
(315)
|
$ 9
|
|
|
|
| Depreciation and amortization |
|
|
|
|
168
|
168
|
|
|
|
| Interest accretion |
|
|
|
|
|
|
|
|
|
| Mark to market on warrants |
|
|
|
|
|
|
|
|
|
| Stock-based compensation |
|
|
|
|
|
|
|
|
|
| Bad debt expense |
|
|
|
|
|
|
|
|
|
| Other gains and expenses, net |
|
|
|
|
|
|
|
|
|
| Decrease (increase) in accounts receivable |
|
|
|
|
141
|
|
|
|
|
| (Increase) decrease in other current assets |
|
|
|
|
|
|
|
|
|
| (Decrease) increase in accounts payable |
|
|
|
|
103
|
|
|
|
|
| (Decrease) increase in accrued salaries and bonus |
|
|
|
|
|
(120)
|
|
|
|
| (Decrease) increase in accrued liabilities |
|
|
|
|
(97)
|
(57)
|
|
|
|
| Increase in long-term liabilities |
|
|
|
|
|
|
|
|
|
| Net cash used in operating activities |
|
|
|
|
|
|
|
|
|
| Purchase of property and equipment |
|
|
|
|
|
|
|
|
|
| Sale of property and equipment |
|
|
|
|
|
|
|
|
|
| Net cash provided by investing activity |
|
|
|
|
|
|
|
|
|
| Issuance of common stock, net of expenses |
|
|
|
|
|
|
|
|
|
| Borrowings on Line of Credit, net |
|
|
|
|
|
|
|
|
|
| Issuance of Series B preferred stock, net of expenses |
|
|
|
|
|
|
|
|
|
| Net cash provided by financing activities |
|
|
|
|
|
|
|
|
|
| Net increase (decrease) in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents - beginning |
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents - ending |
|
|
|
|
|
|
|
|
|
| Restatement Amount [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
|
|
|
|
|
|
|
|
|
| Balance |
|
|
|
|
|
|
|
|
|
| Common stock issued |
|
|
|
|
|
|
|
|
|
| Restricted stock issued |
|
|
|
|
|
|
|
|
|
| Restricted stock issued, shares |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
|
|
|
|
|
|
| Balance |
|
|
|
|
|
|
|
|
|
| Restatement Amount [Member] | Treasury Stock [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
|
|
|
|
|
|
|
|
|
| Balance |
|
|
|
|
|
|
|
|
|
| Balance, shares |
|
|
|
|
|
|
|
|
|
| Treasury stock purchased |
|
|
|
|
|
|
|
|
|
| Balance |
|
|
|
|
|
|
|
|
|
| Balance, shares |
|
|
|
|
|
|
|
|
|
| Restatement Amount [Member] | Additional Paid-in Capital [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
|
|
|
|
|
|
|
|
|
| Balance |
|
|
|
|
|
|
|
|
|
| Common stock issued through market sales |
|
|
|
|
|
|
|
|
|
| Common stock issued through offerings |
|
|
|
|
|
|
|
|
|
| Extinguishment of Series A Shares |
|
|
|
|
|
|
|
|
|
| Beneficial Conversion Feature in connection with Series B Issuance |
|
|
|
|
|
|
|
|
|
| Amortization of Beneficial Conversion Feature |
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
| Balance |
|
|
|
|
|
|
|
|
|
| Restatement Amount [Member] | Accumulated Deficit [Member] |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
(17,820)
|
(17,736)
|
(17,483)
|
(17,492)
|
(17,820)
|
(17,483)
|
(17,820)
|
$ (17,505)
|
|
| Balance |
(17,736)
|
(17,505)
|
(17,399)
|
(17,492)
|
(17,505)
|
(17,492)
|
|
|
|
| Adoption of ASC 842 |
|
|
|
|
|
|
|
|
|
| Net loss |
(84)
|
(231)
|
(84)
|
93
|
|
|
|
|
|
| Balance |
$ (17,820)
|
$ (17,736)
|
$ (17,483)
|
$ (17,399)
|
$ (17,820)
|
$ (17,483)
|
|
|
|
| Restatement Amount [Member] | Series B [Member] |
|
|
|
|
|
|
|
|
|
| Preferred stock value |
|
|
|
|
|
|
|
|
|